A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
Recruiting · NCT07330674 · Registry updated 2026-02-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 | 2026-02-06 | NCT07330674 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aptabio Therapeutics, Inc. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dallas Clinical Research Unit | Dallas | United States | 1 |